These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12843973)

  • 1. [Clear cell carcinoma of the ovary simulating a yolk sac tumor].
    Bahri I; Boudawara T; Khabir A; Beyrouti MI; Frikha M; Jlidi R
    Ann Pathol; 2003 Apr; 23(2):165-8. PubMed ID: 12843973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
    Cao D; Guo S; Allan RW; Molberg KH; Peng Y
    Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear cell carcinoma simulating the "endometrioid-like variant" of yolk sac tumor.
    Ballotta MR; Bianchini E; Borghi L; Fortini RM
    Pathologica; 1995 Feb; 87(1):87-90. PubMed ID: 7567174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear cell gynecologic carcinomas: about 5 cases.
    Haifa B; Ines Z; Manel N; Amira D; Sonia Z; Laila N; Houda M; Anis H; Raja F
    Pan Afr Med J; 2019; 34():87. PubMed ID: 31934230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE; Pate LL; Longacre TA
    Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondromatous differentiation in clear cell carcinoma of the ovary: a rare finding challenging the differential diagnosis.
    Akbulut M; Zekioglu O; Terek MC; Ozdemir N
    Arch Gynecol Obstet; 2008 Dec; 278(6):569-72. PubMed ID: 18343935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant ovarian tumor composed of endometrioid adenocarcinoma, clear cell adenocarcinoma, squamous cell carcinoma, yolk sac tumor and immature teratoma with prominent neuroectodermal and rhabdomyosarcomatous differentiation: a case study.
    Ohishi Y; Kaku T; Kaneki E; Wake N; Tsuneyoshi M
    Gynecol Oncol; 2007 May; 105(2):548-52. PubMed ID: 17341430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-fetoprotein-producing serous carcinoma of the uterus metastasizing to the ovaries, mimicking primary ovarian yolk sac tumor: a case report and review of the literature.
    Tran TA; Ortiz HB; Holloway RW; Bigsby GE; Finkler NJ
    Int J Gynecol Pathol; 2007 Jan; 26(1):66-70. PubMed ID: 17197899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
    Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT
    Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary.
    Rebischung C; Pautier P; Morice P; Lhomme C; Duvillard P
    Gynecol Oncol; 2000 Apr; 77(1):203-5. PubMed ID: 10739713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endodermal sinus tumour and clear cell ovarian cancer.
    O'Brien ME; Perren T; Tan S; Fisher C; Wiltshaw E
    Ann Oncol; 1994 Oct; 5(8):753-6. PubMed ID: 7530035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yolk sac tumor in a young girl: a case report.
    Razzi S; Luisi S; Gabbanini M; Lazzeri L; Mazzini M; Petraglia F
    Gynecol Endocrinol; 2005 Jun; 20(6):334-5. PubMed ID: 16019383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative treatment of big yolk sac tumour of the ovary in young girl.
    Beurdeley M; Gauthier T; Piguet C; Fourcade L
    J Visc Surg; 2010 Aug; 147(4):e265-7. PubMed ID: 20920902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Yao CW; Loh SH; Cheng MF; Hsieh DS; Bai CY
    Int J Gynecol Pathol; 2006 Apr; 25(2):140-6. PubMed ID: 16633062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
    Sangoi AR; Soslow RA; Teng NN; Longacre TA
    Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary combined chemotherapy following removal of an endodermal sinus tumor or yolk-sac tumor of the ovary (author's transl)].
    Frick R; Rummel H; Wurster K; Kaufmann M
    Geburtshilfe Frauenheilkd; 1976 Nov; 36(11):946-50. PubMed ID: 62689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian endometrioid carcinoma with yolk sac component in a young patient: a diagnostic and therapeutic dilemma.
    Kane SV; Wuntkal R; Ramadwar M; Tongaonkar HB
    Aust N Z J Obstet Gynaecol; 2004 Aug; 44(4):364-6. PubMed ID: 15282017
    [No Abstract]   [Full Text] [Related]  

  • 19. The yolk sac tumor: reflections on a remarkable neoplasm and two of the many intrigued by it-Gunnar Teilum and Aleksander Talerman-and the bond it formed between them.
    Young RH
    Int J Surg Pathol; 2014 Dec; 22(8):677-87. PubMed ID: 25395492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinomas of ovary and lung with clear cell features: can immunohistochemistry help in differential diagnosis?
    Howell NR; Zheng W; Cheng L; Tornos C; Kane P; Pearl M; Chalas E; Liang SX
    Int J Gynecol Pathol; 2007 Apr; 26(2):134-40. PubMed ID: 17413979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.